-
CMP Development, LLC v. Amneal Pharmaceuticals LLC DC CAFC
- 1:21-cv-00549
- D. Del.
- Judge: Maryellen Noreika
- Filed: 04/16/2021
- Closed: 10/11/2023
- Latest Docket Entry: 01/26/2024
- PACER
- Docket updated daily
1
Plaintiff
1
Defendant
1
Accused
Product
5
Patents-in-Suit
909
Days in
Litigation
-
CMP Development, LLC v. Amneal Pharmaceuticals LLC DC CAFC
- 1:21-cv-00549
- D. Del.
- Judge: Maryellen Noreika
- Filed: 04/16/2021
- Closed: 10/11/2023
- Latest Docket Entry: 01/26/2024
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Amneal Pharmaceuticals, LLC
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic version of CMP’s CaroSpir® oral suspension 25 mg/5 mL | US 10,624,906 B1 |
1, 8
|
No infringement
Entry 127
|
| Generic version of CMP’s CaroSpir® oral suspension 25 mg/5 mL | US 10,660,907 B1 |
1, 10
|
No infringement
Entry 127
|
| Generic version of CMP’s CaroSpir® oral suspension 25 mg/5 mL | US 10,888,570 B2 |
1, 7, 8, 9, 10
|
No infringement
Entry 127
|
